Ongoing serious bacterial infections at the time of screening.
Other significant medical conditions that could increase the risk to the subject.
Females who are pregnant, breast feeding, or planning a pregnancy during the course study.
Participation in a study with an Investigational Medicinal Product (IMP) other than IgPro20 within three months prior to enrollment.
